Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain
重新填充小胶质细胞耗尽的成人大脑的细胞的起源、特性和治疗潜力
基本信息
- 批准号:10335278
- 负责人:
- 金额:$ 37.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-15 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdultAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-ProteinAppearanceAstrocytesAxonBackBehaviorBrainBrain DiseasesCellsClinicalClinical TrialsCognitionCytoskeletonDendritic SpinesDevelopmentDiseaseDisease ProgressionEndothelial CellsGene ExpressionGene Expression ProfileHealthHomeostasisInflammationInjuryLong-Term PotentiationMacrophage Colony-Stimulating Factor ReceptorMicrogliaModelingMorphologyMusMyelogenousMyeloid CellsNeuronsNucleosomesOligodendrogliaPathologyPericytesPhagocytesPhenotypeProliferatingPropertyRecovery of FunctionReportingRouteSignal TransductionSourceStainsStreamSynapsesSynaptic plasticityTherapeuticTimeTissuesWithdrawalWorkaging brainbrain cellcell typedensitydrug withdrawalfunctional outcomesimprovedinhibitorjuvenile animalmacrophagemouse modelneurogenesisneuroinflammationnovelpostnatal developmentresponserestorationtranscriptometranscriptome sequencingwhite matter
项目摘要
Abstract:
We discovered microglia in the adult brain are dependent on signaling through the colony-stimulating factor 1
receptor (CSF1R), and identified several CSF1R inhibitors that crossed into the brain, leading to the
elimination of most of the microglia. This remarkable phenomenon has been widely replicated and is now a
standard in the field to explore microglial function in health and disease, and clinical trials are being
conducted/planned as a result. We also found that we could eliminate microglia for as long as we continued
treatment, but upon drug withdrawal, repopulation of the microglial tissue occurred rapidly from proliferating
cells throughout the brain that formed a new microglial tissue in ~14 days. We found we could use this to
“reset” the inflamed microglial tissue after injury or in aging, and promote functional recovery/cognition. In this
continuation, we seek to understand the source and properties of these repopulating cells that become
microglia, and study how they modulate neuronal gene expression to rejuvenate the aged brain and fully
restore long-term potentiation to that of a young animal. In addition, we describe a second slower source of
microglial repopulation, that originates in specific brain niches – the rostral migratory stream (RMS) and
associated projecting axonal tracts. This “alternative” repopulation is only unmasked by the complete
elimination of microglia. These “alternative” cells arise from unknown cells within these brain niches, and
eventually can break out from the white matter tracts and fill the cortex/brain. These cells never attain the
numbers, morphologies, or gene expression of microglia, but resemble microglia found in the RMS, which have
pro-neurogenesis and increased phagocytotic capabilities than other microglia. We will determine the source
of these “alternative” cells, and the consequences of filling the brain with them, including if they have any
therapeutic potential, in a mouse model of Alzheimer's disease.
抽象的:
我们发现成人大脑中的小胶质细胞取决于通过刺激因子1的信号传导
受体(CSF1R),并鉴定
消除大多数小胶质细胞。这种非凡的现象已被广泛复制,现在是
现场探索健康和疾病中小胶质功能的标准,临床试验正在
结果进行/计划。我们还发现,只要我们继续
治疗,但在戒断药物后,小胶质细胞组织的重生迅速发生
整个大脑的细胞在约14天内形成了新的小胶质细胞组织。我们发现我们可以使用它
“重置”受伤或衰老后发炎的小胶质细胞组织,并促进功能恢复/认知。在这个
继续,我们试图了解这些重现的细胞的来源和特性
小胶质细胞,并研究它们如何调节神经元基因表达以使老化的大脑恢复活力并完全
恢复了年轻动物的长期潜力。此外,我们描述了第二个较慢的来源
小胶质细胞的重生,起源于特定的脑壁ches - 延髓迁移流(RMS)和
相关的投射轴突区。这种“替代”重新群仅由完整的
消除小胶质细胞。这些“替代”细胞来自这些脑壁che中未知细胞,以及
最终可以从白质区域爆发,并填充皮质/大脑。这些细胞永远不会达到
小胶质细胞的数量,形态或基因表达,但类似于RMS中的小胶质细胞,
与其他小胶质细胞相比,亲神经发生和增加的吞噬能力。我们将确定来源
这些“替代”细胞以及用它们充满大脑的后果,包括它们是否有任何
在阿尔茨海默氏病小鼠模型中的治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kim Green其他文献
Kim Green的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kim Green', 18)}}的其他基金
Neuroimmunology Training Program at the University of California, Irvine
加州大学欧文分校神经免疫学培训项目
- 批准号:
10411051 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别:
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease
衰老和阿尔茨海默病小鼠模型中的细胞类型特异性神经回路连接组
- 批准号:
10620788 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别:
Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease
衰老和阿尔茨海默病小鼠模型中的细胞类型特异性神经回路连接组
- 批准号:
10430810 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别:
Neuroimmunology Training Program at the University of California, Irvine
加州大学欧文分校神经免疫学培训项目
- 批准号:
10630973 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别:
The lipid amidase NAAA as a therapeutic target for Alzheimer's disease
脂质酰胺酶 NAAA 作为阿尔茨海默病的治疗靶点
- 批准号:
10118584 - 财政年份:2020
- 资助金额:
$ 37.35万 - 项目类别:
Disease Model Development and Phenotyping Project
疾病模型开发和表型分析项目
- 批准号:
10592223 - 财政年份:2017
- 资助金额:
$ 37.35万 - 项目类别:
Disease Model Development and Phenotyping Project
疾病模型开发和表型分析项目
- 批准号:
10708166 - 财政年份:2017
- 资助金额:
$ 37.35万 - 项目类别:
Origins, properties, and therapeutic potential of cells that repopulate the microglia-depleted adult brain
重新填充小胶质细胞耗尽的成人大脑的细胞的起源、特性和治疗潜力
- 批准号:
10554378 - 财政年份:2014
- 资助金额:
$ 37.35万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Protein modification and the aging phenotype of human skeletal muscle
蛋白质修饰与人类骨骼肌的衰老表型
- 批准号:
10593791 - 财政年份:2023
- 资助金额:
$ 37.35万 - 项目类别:
Molecular and Cell Biological Foundations of Proteostress-Induced Neuronal Extrusion
蛋白质应激诱导的神经元挤压的分子和细胞生物学基础
- 批准号:
10753902 - 财政年份:2023
- 资助金额:
$ 37.35万 - 项目类别:
Exploring The Brain Enriched E3 Ubiquitin Ligase TRIM9 in Alzheimer's Disease
探索大脑富含 E3 泛素连接酶 TRIM9 在阿尔茨海默病中的作用
- 批准号:
10467201 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别:
Mechanisms of cardiomyocyte dysfunction due to the E258K-MYBPC3 mutation modeled in patient-derived cardiomyocytes
在患者来源的心肌细胞中建模 E258K-MYBPC3 突变引起的心肌细胞功能障碍的机制
- 批准号:
10462968 - 财政年份:2022
- 资助金额:
$ 37.35万 - 项目类别: